bioAffinity Technologies receives US patent allowance for lung cancer test
Go back to bioAffinity Technologies receives US patent allowance for lung cancer test| (NASDAQ: BIAF) | Delayed: 8.45 +0.75 (9.74%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $7.70 | 52 Week High | $ | |||
| Open | $8.28 | 52 Week Low | $ | |||
| Day High | $9.00 | P/E | N/A | |||
| Day Low | $8.26 | EPS | $ | |||
| Volume | 537,114 | |||||
| (NASDAQ: BIAFW) | Delayed: 0.26 -0.03 (10.34%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.29 | 52 Week High | $ | |||
| Open | $0.32 | 52 Week Low | $ | |||
| Day High | $0.32 | P/E | N/A | |||
| Day Low | $0.26 | EPS | $ | |||
| Volume | 500 | |||||

